Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 2000, p. 1438-1442, Vol. 44, No. 6
Department of
Pathology,1 National Cheng Kung University
Medical Center, and Department of Medical
Technology,2 National Cheng Kung University
Medical College, Tainan, Taiwan
Received 19 October 1999/Returned for modification 26 January
2000/Accepted 29 February 2000
Twenty (8.5%) of 234 nonrepetitive clinical isolates of
Klebsiella pneumoniae from southern Taiwan were found to
produce extended-spectrum
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Prevalence of SHV-12 among Clinical Isolates of
Klebsiella pneumoniae Producing Extended-Spectrum
-Lactamases and Identification of a Novel AmpC Enzyme
(CMY-8) in Southern Taiwan
-lactamases (ESBLs): 10 strains produced
SHV-12, 4 produced SHV-5, 2 produced a non-TEM non-SHV ESBL with a pI
of 8.3, 3 produced a novel AmpC
-lactamase designated CMY-8 with a
pI of 8.25, and 1 produced SHV-12 and an unidentified AmpC enzyme with
a pI of 8.2. The CMY-8 enzyme confers a resistance phenotype similar to CMY-1 and MOX-1, and sequence comparisons showed high homologies (>95%) of nucleotide and amino acid sequences among these three enzymes. Plasmid and pulse-field gel electrophoresis analyses revealed
that all isolates harboring an SHV-derived ESBL were genetically
unrelated, indicating that dissemination of resistance plasmids is
responsible for the spread of SHV ESBLs among K. pneumoniae in this area. All three isolates carrying CMY-8 had identical genotypic
patterns, suggesting the presence of an epidemic strain.
*
Corresponding author. Mailing address: Department of
Medical Technology, National Cheng Kung University Medical College, No. 1 University Rd., Tainan, Taiwan 70101, Taiwan. Phone: 886-6-2353535, ext. 5775. Fax: 886-6-2363956. E-mail:
jjwu{at}mail.ncku.edu.tw.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |